LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson’s Disease

Overview of attention for article published in Current Medical Science, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#11 of 366)
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 33 Mendeley
citeulike: 1 CiteULike

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

Alzforum, 14 Dec 2018

. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.